let the good times rollI’m thinking about the next few announcements and how any one of them has the potential to spike the share price… partnership, nci trials, glio startup, etc.
Hey, after taking two years to get going on the (phase II) NCI trials, maybe they’ll have everything so carefully planned that we’ll fly through. Multi-centre, US trials measuring
efficacy beginning as soon as next week… wonder what that will do for the share price?
Ultimately, all will pale in comparison with the Marsden Ph1 results. Seriously, how much of a hint do investors need before they realize reolysin is curing cancer in terminally ill patients right now?